Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 27, 2024British Journal of Haematology

Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification

View Full Paper
Ask AI
Bookmark
Share

Authors

AOAdrián Mosquera OrgueiraMPManuel Pérez‐EncinasNVNicolás Díaz Varela

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Orgueira et al. (2024) studied this question.

synapsesocial.com/papers/68e77584b6db6435876eaa68https://doi.org/10.1111/bjh.19341
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Assessing the Relevance of Non-molecular Prognostic Systems for Myelodysplastic Syndrome in the Era of Next-Generation Sequencing2024 · 3 citations
  2. 2Validation of the Molecular International Prognostic Scoring System (IPSS-M) for myelodysplastic neoplasms (MDS) and comparison with the revised International Prognostic Scoring System (IPSS-R) in Chinese Population: A Multicenter Retrospective Study.2024 · 1 citations
  3. 3Comparative evaluation of ipss-m and cpss-mol in CMML: Impact of molecular markers on prognosis2025
  4. 4IPSS, IPSS-R and IPSS-M had no identical prognostic power depending on treatment in myelodysplastic syndromes2026
  5. 5ELN vs. IPSS-M in MDS/AML: Which Prognostic System Should Guide Clinical Decision-Making?2026